The Patient Definition, Eligibility & Required Documentation
This white paper provides an overview of the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) 340B Drug Discount Pricing Program with a particular focus on aspects of legislation and regulation that impact patient definition and referral prescriptions.
Features in-depth analysis of patient definition by describing:
- HHS and Apexus positions with respect to patient and provider eligibility.
- Current and historical guidelines on patient definition with an emphasis on referral prescriptions.
- An exclusive data analysis from eight 340B covered entity (CE) contract pharmacies and vendor partners revealing overall referral prescription capture rate at 2% and specialty capture nearly absent.
- Operational and technical challenges involved in capturing referral prescriptions in a manner that satisfies HRSA audits.
- How 340B Recovery solves current challenges.
